Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Short term Debt (2021 - 2026)

Journey Medical filings provide 4 years of Short term Debt readings, the most recent being $5.6 million for Q3 2025.

  • On a quarterly basis, Short term Debt changed N/A to $5.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.6 million, a N/A change, with the full-year FY2022 number at $2.9 million, up 263.05% from a year prior.
  • Short term Debt hit $5.6 million in Q3 2025 for Journey Medical, up from $3.8 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $9.9 million in Q2 2023 to a low of $812000.0 in Q4 2021.
  • Median Short term Debt over the past 4 years was $3.8 million (2025), compared with a mean of $5.0 million.
  • The widest YoY moves for Short term Debt: up 263.05% in 2022, down 263.05% in 2022.
  • Journey Medical's Short term Debt stood at $812000.0 in 2021, then surged by 263.05% to $2.9 million in 2022, then soared by 237.25% to $9.9 million in 2023, then plummeted by 43.42% to $5.6 million in 2025.
  • The last three reported values for Short term Debt were $5.6 million (Q3 2025), $3.8 million (Q2 2025), and $1.9 million (Q1 2025) per Business Quant data.